117 related articles for article (PubMed ID: 26207113)
21. High-dose rate intracavitary brachytherapy pretreatment dwell position verification using a transparent applicator.
Otani Y; Sumida I; Nose T; Shimamoto S; Okubo H; Ogawa K
J Appl Clin Med Phys; 2018 Sep; 19(5):428-434. PubMed ID: 29959815
[TBL] [Abstract][Full Text] [Related]
22. A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate
Ma Y; Vijande J; Ballester F; Tedgren ÅC; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith R; Chamberland MJP; Thomson RM; Verhaegen F; Beaulieu L
Med Phys; 2017 Nov; 44(11):5961-5976. PubMed ID: 28722180
[TBL] [Abstract][Full Text] [Related]
23. Uncertainties in assessment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator.
Berger D; Dimopoulos J; Georg P; Georg D; Pötter R; Kirisits C
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1451-9. PubMed ID: 17289290
[TBL] [Abstract][Full Text] [Related]
24. Multihelix rotating shield brachytherapy for cervical cancer.
Dadkhah H; Kim Y; Wu X; Flynn RT
Med Phys; 2015 Nov; 42(11):6579-88. PubMed ID: 26520749
[TBL] [Abstract][Full Text] [Related]
25. Radiography-based treatment planning compared with computed tomography (CT)-based treatment planning for intracavitary brachytherapy in cancer of the cervix: analysis of dose-volume histograms.
Kim RY; Pareek P
Brachytherapy; 2003; 2(4):200-6. PubMed ID: 15062127
[TBL] [Abstract][Full Text] [Related]
26. The evaluation of a 2D diode array in "magic phantom" for use in high dose rate brachytherapy pretreatment quality assurance.
Espinoza A; Petasecca M; Fuduli I; Howie A; Bucci J; Corde S; Jackson M; Lerch ML; Rosenfeld AB
Med Phys; 2015 Feb; 42(2):663-673. PubMed ID: 28102606
[TBL] [Abstract][Full Text] [Related]
27. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
Davidson MT; Yuen J; D'Souza DP; Batchelar DL
Brachytherapy; 2008; 7(1):37-42. PubMed ID: 18299111
[TBL] [Abstract][Full Text] [Related]
28. Tandem-ring dwell time ratio in Nigeria: dose comparisons of two loading patterns in standard high-dose-rate brachytherapy planning for cervical cancer.
Ibhade OR; Oyeyemi OE; Idayat AB; Atara I N
J Contemp Brachytherapy; 2015 Apr; 7(2):161-70. PubMed ID: 26034498
[TBL] [Abstract][Full Text] [Related]
29. Sci-Sat AM: Brachy - 08: MRI-guided planning and maximum achievable HR-CTV doses in cervix brachytherapy.
Menon G; Sloboda R; Ghosh S; Dundas G; Pearcey R; Huang F
Med Phys; 2012 Jul; 39(7Part4):4646. PubMed ID: 28516636
[TBL] [Abstract][Full Text] [Related]
30. Design and testing of a phantom and instrumented gynecological applicator based on GaN dosimeter for use in high dose rate brachytherapy quality assurance.
Guiral P; Ribouton J; Jalade P; Wang R; Galvan JM; Lu GN; Pittet P; Rivoire A; Gindraux L
Med Phys; 2016 Sep; 43(9):5240. PubMed ID: 27587055
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of anatomy-based dwell position and inverse optimization in high-dose-rate brachytherapy of prostate cancer: a dosimetric comparison to a conventional cylindrical dwell position, geometric optimization, and dose-point optimization.
Yoshioka Y; Nishimura T; Kamata M; Harada H; Kanazawa K; Fuji H; Murayama S
Radiother Oncol; 2005 Jun; 75(3):311-7. PubMed ID: 15890425
[TBL] [Abstract][Full Text] [Related]
32. Development and Testing of a Magnetic Resonance (MR) Conditional Afterloader for Source Tracking in Magnetic Resonance Imaging-Guided High-Dose-Rate (HDR) Brachytherapy.
Beld E; Seevinck PR; Schuurman J; Viergever MA; Lagendijk JJW; Moerland MA
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):960-968. PubMed ID: 29891205
[TBL] [Abstract][Full Text] [Related]
33. Dwell position inaccuracy in the Varian GammaMed HDR ring applicator.
Stern RL; Liu T
J Appl Clin Med Phys; 2010 Sep; 11(4):3158. PubMed ID: 21081871
[TBL] [Abstract][Full Text] [Related]
34. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.
Kirisits C; Pötter R; Lang S; Dimopoulos J; Wachter-Gerstner N; Georg D
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):901-11. PubMed ID: 15936576
[TBL] [Abstract][Full Text] [Related]
35. Influence of dwell time homogeneity error weight parameter on treatment plan quality in inverse optimized high-dose-rate cervix brachytherapy using SagiPlan.
Mosleh-Shirazi MA; Shahcheraghi-Motlagh E; Gholami MH; Shakibafard A; Karbasi S; Fardid R
J Contemp Brachytherapy; 2019 Jun; 11(3):256-266. PubMed ID: 31435433
[TBL] [Abstract][Full Text] [Related]
36. A quality assurance tool for high-dose-rate brachytherapy.
Rickey DW; Sasaki D; Bews J
Med Phys; 2010 Jun; 37(6):2525-32. PubMed ID: 20632564
[TBL] [Abstract][Full Text] [Related]
37. Direct reconstruction of the Vienna applicator on MR images.
Berger D; Dimopoulos J; Pötter R; Kirisits C
Radiother Oncol; 2009 Nov; 93(2):347-51. PubMed ID: 19625096
[TBL] [Abstract][Full Text] [Related]
38. Optimization in high dose rate brachytherapy for utero-vaginal applications.
Cetingöz R; Ataman OU; Tuncel N; Sen M; Kinay M
Radiother Oncol; 2001 Jan; 58(1):31-6. PubMed ID: 11165679
[TBL] [Abstract][Full Text] [Related]
39. The impact of activating source dwell positions outside the CTV on the dose to treated normal tissue volumes in TRUS guided 3D conformal interstitial HDR brachytherapy of prostate cancer.
Karlsson L; Thunberg P; Johansson B; Persliden J
J Contemp Brachytherapy; 2014 Oct; 6(3):282-8. PubMed ID: 25337130
[TBL] [Abstract][Full Text] [Related]
40. Electromagnetic tracking (EMT) technology for improved treatment quality assurance in interstitial brachytherapy.
Kellermeier M; Herbolzheimer J; Kreppner S; Lotter M; Strnad V; Bert C
J Appl Clin Med Phys; 2017 Jan; 18(1):211-222. PubMed ID: 28291934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
